2008
DOI: 10.1007/s00213-008-1357-7
|View full text |Cite
|
Sign up to set email alerts
|

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Abstract: The data further support the potential of GABAA alpha5 receptors as a target for cognition-enhancing drugs. The dual binding and functional selectivity offers an ideal profile for cognition-enhancing effects without the unwanted side effects associated with activity at other GABAA receptor subtypes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
139
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 143 publications
(151 citation statements)
references
References 58 publications
10
139
2
Order By: Relevance
“…The results presented here will be of potential therapeutic interest because they suggest a cellular mechanism to account for the memory-enhancing properties of inhibitors of ␣5GABA A Rs Ballard et al, 2009). Indiscriminant reduction in GABA A R-mediated inhibition by nonselective antagonists facilitates synaptic plasticity (Wigström and Gustafsson, 1983), increases vigilance (Ferraro et al, 1999), and improves memory performance (Zarrindast et al, 2002); however, these nonselective drugs have no therapeutic utility because of their proconvulsant and anxiogenic properties (Ben-Ari et al, 2007).…”
Section: Discussionmentioning
confidence: 94%
“…The results presented here will be of potential therapeutic interest because they suggest a cellular mechanism to account for the memory-enhancing properties of inhibitors of ␣5GABA A Rs Ballard et al, 2009). Indiscriminant reduction in GABA A R-mediated inhibition by nonselective antagonists facilitates synaptic plasticity (Wigström and Gustafsson, 1983), increases vigilance (Ferraro et al, 1999), and improves memory performance (Zarrindast et al, 2002); however, these nonselective drugs have no therapeutic utility because of their proconvulsant and anxiogenic properties (Ben-Ari et al, 2007).…”
Section: Discussionmentioning
confidence: 94%
“…Like other α 5 GABA A R negative modulators, the imidazo-triazolo-benzodiazepine RO4938581 managed to improve the cognitive performance of rats in the DMTP and Morris water maze models. In addition, RO4938581 enhanced the prefrontal executive function of cynomolgus monkeys in an object retrieval task without having any adverse effects on anxiety, convulsion, motor coordination or muscle strength [52,53]. RO4938581 also significantly improved the performance of scopolamine-and diazepam-induced memory-impaired rats in the DMTP and…”
Section: Nootropicmentioning
confidence: 92%
“…Morris water maze, respectively [52,53]. PWZ-029 is unusual in that it inhibits α 5 GABA A Rs at nanomolar concentrations but potentiates other GABA A R isoforms at much lower potencies [54,55].…”
Section: Nootropicmentioning
confidence: 99%
See 1 more Smart Citation
“…Diazepam (10 mg/kg) or riluzole (3 and 10 mg/kg) was prepared as described previously (6) and administered orally 60 min prior to the training trial. The dose of diazepam was chosen based on previous experiments (15). We have previously demonstrated that 3 mg/kg but not 10 mg/kg of riluzole has anxiolytic-like effects in rats (6).…”
Section: Short Communicationmentioning
confidence: 99%